9 Healthcare Stocks Moving In Wednesday's Pre-Market Session


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


Gainers

  • SINTX Technologies, Inc. (NASDAQ:SINT) shares increased by 19.6% to $2.20 during Wednesday's pre-market session. The market cap stands at $4.8 million.
  • Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) stock surged 7.1% to $2.72. The market cap stands at $55.2 million. The most recent rating by Ladenburg Thalmann, on September 11, is at Buy, with a price target of $7.00.
  • Nabriva Therapeutics, Inc. (NASDAQ:NBRV) stock surged 4.5% to $2.07. The market value of their outstanding shares is at $146.7 million.
  • argenx, Inc. (NASDAQ:ARGX) stock increased by 3.4% to $131.69. The most recent rating by Credit Suisse, on November 05, is at Neutral, with a price target of $137.00.
  • BioLine Rx, Inc. (NASDAQ:BLRX) shares moved upwards by 3.2% to $2.57.
  • Grifols, Inc. (NASDAQ:GRFS) stock increased by 1.8% to $21.76. According to the most recent rating by Santander, on October 28, the current rating is at Buy.
  • Amarin Corp, Inc. (NASDAQ:AMRN) shares moved upwards by 1.8% to $21.31. The market cap stands at $5.8 billion. The most recent rating by Aegis Capital, on October 31, is at Buy, with a price target of $23.00.

 

Losers

  • Nuvectra, Inc. (NASDAQ:NVTR) stock declined 74.8% to $0.35 during Wednesday's pre-market session. The market cap stands at $25.5 million. According to the most recent rating by Raymond James, on November 13, the current rating is at Market Perform.
  • Tilray, Inc. (NASDAQ:TLRY) shares declined 3.1% to $20.91. The market value of their outstanding shares is at $2.2 billion. The most recent rating by Cantor Fitzgerald, on November 05, is at Neutral, with a price target of $20.00.

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralHealthcare Stocks Pre-Market MoversTop Gainers